Influence of demographic, lymphoma-specific, and HIV-specific factors on outcome
. | Overall survival . | . | . | ||
---|---|---|---|---|---|
Prognostic factors . | No. . | Univariate HR*(95% CI) . | Multivariate HR†(95% CI) . | ||
Risk factor for HIV infection | |||||
Intravenous drug use | 47‡ | 1§ | 1§ | ||
Male homosexuality | 22 | 2.41 (1.11-5.23)∥ | 2.34 (1.07-5.08)∥ | ||
Histology | |||||
DLBCL | 52‡ | 1§ | 1§ | ||
Burkitt lymphoma | 21 | 2.60 (1.20-5.64)¶ | 2.24 (1.01-4.97)# | ||
HIV viral load at the end of R-CDE | |||||
Undetectable | 36‡ | 1§ | 1§ | ||
Detectable | 26 | 2.39 (1.10-5.18)∥ | 1.96 (0.88-4.36)** |
. | Overall survival . | . | . | ||
---|---|---|---|---|---|
Prognostic factors . | No. . | Univariate HR*(95% CI) . | Multivariate HR†(95% CI) . | ||
Risk factor for HIV infection | |||||
Intravenous drug use | 47‡ | 1§ | 1§ | ||
Male homosexuality | 22 | 2.41 (1.11-5.23)∥ | 2.34 (1.07-5.08)∥ | ||
Histology | |||||
DLBCL | 52‡ | 1§ | 1§ | ||
Burkitt lymphoma | 21 | 2.60 (1.20-5.64)¶ | 2.24 (1.01-4.97)# | ||
HIV viral load at the end of R-CDE | |||||
Undetectable | 36‡ | 1§ | 1§ | ||
Detectable | 26 | 2.39 (1.10-5.18)∥ | 1.96 (0.88-4.36)** |